Skip to main content

BATF2 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (AB257855), expandable thumbnail
  • Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (AB257855), expandable thumbnail

Key facts

Cell type
A549
Species or organism
Human
Tissue
Lung
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3.

Alternative names

What's included?

1 Kit
Components
Human BATF2 knockout A549 cell lysate
1 x 100 µg
Human wild-type A549 cell lysate
1 x 100 µg

Recommended products

BATF2 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3.

Key facts

Cell type
A549
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3.
Disease
Carcinoma
Concentration
Loading...

Properties

Gene name
BATF2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes


Knockout cell lysate achieved by CRISPR/Cas9.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

SARI also known as suppressor of AP-1 regulates apoptosis and inflammation in cells. It is a protein with a molecular mass of around 64 kDa. SARI is mainly expressed in immune cells including macrophages and dendritic cells and also found in epithelial tissues. The protein acts mainly in the cytoplasm where it interacts with other molecules to carry out its functions.

Biological function summary

SARI modulates transcription processes involved in immune responses. It forms part of a regulatory complex that includes other proteins like TRAF3 and TBK1 to influence NF-κB signaling pathways. Through this complex SARI can suppress certain transcription factors thereby regulating gene expression linked to inflammation. This regulation helps maintain balanced immune responses ensuring cells do not overreact to stimuli.

Pathways

SARI interacts with the tumor necrosis factor (TNF) and toll-like receptor (TLR) signaling pathways. In these pathways SARI influences how cells respond to cytokines and infectious agents. It achieves this by interacting with key pathway proteins such as TRAF3 and RIPK1. These interactions allow SARI to mediate the downstream effects ultimately affecting cell survival and immune reactions.

Associated diseases and disorders

SARI has roles in inflammatory diseases and cancer. In inflammatory diseases such as rheumatoid arthritis SARI influences the activity of inflammation-related proteins like NF-κB which can exacerbate or alleviate symptoms. In cancer SARI has been implicated in regulating tumor growth and metastasis interacting with other cancer-related proteins such as STAT3. These connections make SARI a potential therapeutic target in managing these conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (ab257855), expandable thumbnail

    Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (ab257855)

    Allele-2: 2 bp deletion in exon3

  • Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (ab257855), expandable thumbnail

    Sanger Sequencing - Human BATF2 (SARI) knockout A549 cell lysate (ab257855)

    Allele-1: 1 bp insertion in exon3

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com